Clinical Trial Update: Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating serplulimab in combination with chemoradiotherapy for stage III-IVA cervical cancer; sponsored by the Cancer Institute …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Serplulimab (serplulimab)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Cervical Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING